Southbrook Organic Vineyards Unveils Exclusive Chef-Signed Wine Collection to Honour Canadian Culinary Stars Competing at the World-Renowned Bocuse d’Or Finale Jan. 27

NIAGARA-ON-THE-LAKE, Ontario, Jan. 21, 2025 (GLOBE NEWSWIRE) — Southbrook Organic Vineyards, the acclaimed biodynamic winery pioneering natural, small-batch winemaking, proudly announces its release of a limited-edition wine collection signed by award-winning Canadian Chef Keith Pears, and Southbrook's founder, Bill Redelmeier. The Southbrook CHEFS CANADA Limited Edition Set marks the winery as the official wine partner […]

Humacyte Announces Planned IND Filing in 2025 to Support First-In-Human Clinical Study of Small-Diameter ATEV(TM) for Coronary Artery Bypass Grafting

(NASDAQ:HUMA), – Plans for filing an IND was agreed with the FDA in a recent meeting – – Positive preclinical results of the small-diameter ATEV were recently presented at The American Heart Association's Scientific Sessions 2024 meeting – DURHAM, N.C., Jan. 21, 2025 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a biotechnology platform company developing

Florida Oncology and Hematology Relocates Fort Myers Clinic

(Other OTC:AONC),(OTC US:AONC), FORT MYERS, Fla., Jan. 21, 2025 (GLOBE NEWSWIRE) — Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has relocated its clinic in Fort Myers to 14551 Hope Center Loop. The newly expanded clinic includes 12 exam rooms, nearly 30 infusion chairs, and an onsite lab. Current or prospective

Strainsforpains, Inc. Sets the Stage for Massive Growth in the Cannabis Industry and AI Innovation

(PinkSheets:EBYH),(Pinksheets:EBYH), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — Strainsforpains, Inc. fka/ E-Buy Home, Inc. (OTC: EBYH). Strainsforpains, Inc. is redefining the future of wellness, cannabis innovation, and AI integration. With a transformative year in the books, the company is poised to disrupt multiple industries and deliver groundbreaking results in 2025. Unparalleled Revenue Growth and

TigerGraph Unleashes the Industry’s Most Innovative Cloud Native Graph Database Platform for Supercharging AI Systems

REDWOOD CITY, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) — The enterprise AI infrastructure and graph database leader TigerGraph today announced Savanna, the next generation cloud offering, extending its market leadership as the graph database designed for companies that need to quickly discover relationships, analyze complex patterns, and make mission critical decisions across large amounts of

ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India

(PinkSheets:VDRM),(Pinksheets:VDRM), LOS ANGELES, Jan. 21, 2025 (GLOBE NEWSWIRE) — ViaDerma, Inc. (OTC Pink: VDRM), an innovator in transdermal drug delivery and topical antibiotic products, is pleased to announce the opening of a satellite office in Dubai to facilitate its ongoing expansion in the Middle East. Local regulations require businesses to maintain a physical office within

CorMedix Announces Collaboration for DefenCath Promotion to the VA and Other Federal Facilities

(NasdaqGM:CRMD), BERKELEY HEIGHTS, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announces it has engaged with WSI PBG, a subsidiary of Golden State Medical Supply, to promote DefenCath(R) to healthcare providers in facilities operated by the

Replimune Announces Biologics License Application Acceptance and Priority Review for RP1 for the Treatment of Advanced Melanoma

(NASDAQ:REPL), WOBURN, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for RP1 (vusolimogene oderparepvec) in combination with nivolumab for patients with advanced

QuestionPro Acquires Happy Market Research Podcast

SAN FRANCISCO, Jan. 21, 2025 (GLOBE NEWSWIRE) — QuestionPro, a global leader in online survey and research services, has acquired the Happy Market Research Podcast (HMRP). With more than 480 episodes and 268,000 listens, the HMRP has become one of the most popular and influential market research industry podcasts. The podcast will now be called

Pacira BioSciences Strengthens Executive Leadership Team with Two Key Appointments

(NASDAQ:PCRX), — Brendan Teehan named Chief Commercial Officer and Krys Corbett named Chief Business Officer — — Key additions expected to support company's 5×30 path to becoming an innovative biopharmaceutical organization — PARSIPPANY, N.J., Jan. 21, 2025 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid

Scroll to Top